Cogstate Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other
companies in this sector in AUSTRALIA :
Mesoblast Ltd
(2020
sales of 47.97 million Australian Dollars [US$36.99 million]
of which 100%
was Adult Stem Cell Development),
Idt Australia Limited.
(14.17 million Australian Dollars [US$10.92 million]
), and
Clinuvel Pharmaceuticals Limited
(33.13 million Australian Dollars [US$25.54 million]
of which 100%
was Biotechnology).
Sales Analysis.
During the year ended June of 2020, sales at
Cogstate Ltd were A$35.36 million (US$27.26 million).
This
is
an
increase of 15.6%
versus 2019, when the company's sales were A$30.58 million.
Despite this increase, sales are still
below the level achieved in 2018, when Cogstate Ltd
reported sales of A$37.49 million.
Sales of Healthcare Market saw an increase
that was more than double the company's growth rate: sales were up
745.8% in 2020, from
A$414,691.60 to A$3.51 million.
Cogstate Ltd also saw significant increases in sales in
Research (up 50.0% to A$387,570.21 )
.